Clinical Trial Update: Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is investigating camrelizumab and apatinib with or without FOLFOX chemotherapy for advanced hepatocellular carcinoma; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)

Snippet

Sponsor: Linhui Peng | Conditions: Hepato Cellular Carcinoma (HCC), Chemotherapy Effect | Phase 3 | Status: RECRUITING